Systemic sclerosis & Raynaud's
Prostaglandin E1 restores endothelial progenitor cell function in systemic sclerosis
Authors' conclusion
PGE1 treatment restores CFU-EC and ECFC levels in SSc patients, suggesting a potential role in repairing vascular damage.
Study context
- Population
- Patients with SSc and RP, and healthy controls
- Participants
- 12 vs 5
- Comparison
- SSc patients with RP vs healthy controls (HCs), before and after intravenous Prostaglandin E1 (PGE1)
- SScn = 12
- HCsn = 5reference
- Outcome
- CFU-EC and ECFC cluster counts before and after PGE1 treatment
Main finding
As reported in the abstract
- CFU-EC clusters significantly increased in SSc after PGE1
- P = 0.02
- ECFC clusters significantly increased in SSc after PGE1
- P = 0.001
Original publication
Prostaglandin E1 restores endothelial progenitor cell function in systemic sclerosis. Rheumatology (Oxford). Published 25 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →